Edition:
United States

RTI Surgical Inc (RTIX.OQ)

RTIX.OQ on NASDAQ Stock Exchange Global Select Market

3.25USD
4:00pm EDT
Change (% chg)

$0.02 (+0.62%)
Prev Close
$3.23
Open
$3.23
Day's High
$3.35
Day's Low
$3.16
Volume
45,905
Avg. Vol
52,207
52-wk High
$7.47
52-wk Low
$2.85

RTIX.OQ

Chart for RTIX.OQ

About

RTI Surgical, Inc. is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company's business primarily consists of six categories, such as spine,... (more)

Overall

Beta: 1.33
Market Cap(Mil.): $187.43
Shares Outstanding(Mil.): 58.03
Dividend: --
Yield (%): --

Financials

  RTIX.OQ Industry Sector
P/E (TTM): 43.54 42.33 39.69
EPS (TTM): 0.07 -- --
ROI: 2.43 11.52 14.44
ROE: 2.47 13.49 15.49

BRIEF-RTI Surgical reports Q2 loss per share $0.05

* RTI surgical Inc says management and board of directors are launching a comprehensive strategic review of company's business lines

Jul 27 2016

BRIEF-RTI Surgical entered into fourth amendment to second amended and restated loan agreement

* Says entered into a fourth amendment to second amended and restated loan agreement, dated as of July 16, 2013 - Sec Filing

Jul 05 2016

BRIEF-RTI Surgical Q1 earnings per share $0.03

* Q1 earnings per share view $0.03 -- Thomson Reuters I/B/E/S

Apr 28 2016

BRIEF-Krensavage says "significant changes" to RTI Surgical board "necessary"

April 13 Krensavage Partners Lp On Rti Surgical Inc

Apr 13 2016

REUTERS BUSINESS NEWS SCHEDULE AT 1600 GMT/11 AM ET

Europe shrugs off pre-G20 China stocks slump, sterling steadies

Feb 25 2016

Drug distributor McKesson to buy two cancer care firms for $1.2 billion

Drug distributor McKesson Corp said it was buying two privately held cancer care service providers, Vantage Oncology LLC and Biologics Inc, for a total of $1.2 billion, to add muscle to its specialty health business.

Feb 25 2016

UPDATE 1-Drug distributor McKesson to buy two cancer care firms for $1.2 bln

Feb 25 Drug distributor McKesson Corp said it was buying two privately held cancer care service providers, Vantage Oncology LLC and Biologics Inc, for a total of $1.2 billion, to add muscle to its specialty health business.

Feb 25 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.